1. Home >
  2. Companies >
  3. Life Science >
  4. Belgium >
  5. Syndesi Therapeutics

Syndesi Therapeutics - Ownership and Business Overview

Life ScienceCompany

Syndesi Therapeutics Ownership

Who owns Syndesi Therapeutics?

Syndesi Therapeutics is owned by AbbVie. It was acquired on March 1, 2022.

Syndesi Therapeutics Business Overview

Where is Syndesi Therapeutics headquartered?

Syndesi Therapeutics is headquartered in Louvain-la-Neuve, Belgium.

What sector is Syndesi Therapeutics in?

Syndesi Therapeutics is a life science company.

When was Syndesi Therapeutics founded?

Syndesi Therapeutics was founded in 2017.

Life Science M&A Summary in 2022

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2022. The largest life science acquisition in 2022 was Horizon Therapeutics Public Limited Company - which was acquired by Amgen for $27.8B.

Join Mergr to view all 297 acquisitions of life science companies in 2022, including 37 acquisitions by private equity firms, and 260 by strategics.

Syndesi Therapeutics

Syndesi Therapeutics SA

Chemin du Cyclotron 6,
Louvain-la-Neuve, 1348
Belgium,
www.syndesitherapeutics.com

Syndesi Therapeutics is a clinical-stage biotechnology company pioneering the development of novel therapeutics that modulate synaptic function to relieve the symptoms of cognitive impairment. The company's unique molecules act pre-synaptically to enhance synaptic efficiency by positively modulating the function of synaptic vesicle protein 2A (SV2A), which plays a central role in regulating neurotransmission. It was created through a partnership between UCB Biopharma SRL and a syndicate of Belgian and international investors to further develop novel SV2A modulators that had been originally discovered by UCB. Syndesi Therapeutics was formed in 2017 and is based in Louvain-la-Neuve, Belgium.


Company Summary

SECTOR

Life Science

Established

2017

 Subscribe to unlock this and 212,813
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 206K M&A Transactions
  • 208K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Syndesi Therapeutics

Life Science Companies , Belgium Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Belgium Companies

Largest Belgium Companies , Acquisitive Belgium Companies , Recently Acquired Belgium Companies , Recently Sold Belgium Companies , Private Belgium Companies , Public Belgium Companies , Acquired Belgium Companies , PE Backed Belgium Companies
Mergr

Product

Company

Legal